 |
|
Researchers Genetically Engineer Microorganisms into Tiny Factories
September 19, 2007BUFFALO, N.Y. -- Microorganisms may soon be efficiently and inexpensively producing novel pharmaceutical compounds, such as flavonoids, that fight aging, cancer or obesity, as well as high-value chemicals, as the result of research being conducted by University at Buffalo researchers.
In work that could transform radically the ways in which many of these compounds are produced commercially, the UB researchers are genetically engineering microorganisms, such as E. coli, into tiny, cellular factories.
Several patents related to this work have been filed by UB. The team also is in discussions with companies in the U.S. and abroad.
First Wave Technologies, Inc., a technology development company based in UB's New York State Center of Excellence in Bioinformatics and Life Sciences, which is collaborating with the UB group, recently received a highly competitive Phase I Small Business Innovation Research (SBIR) grant from the National Science Foundation to focus on the biosynthesis of a popular group of flavonoids called isoflavonoids.
"Ultimately, we want to be able to take a designed E. coli off of the shelf and drop into it the enzymes that constitute a particular biosynthetic pathway in order to make exactly the product we want," said Mattheos A. G. Koffas, Ph.D., assistant professor of chemical and biological engineering in the School of Engineering and Applied Sciences and leader of the UB team.
The UB approach to synthetic chemistry addresses some of the major challenges in conventional industrial production of specialty chemicals.
Through the use of specially adapted bacteria, specialized enzymes and natural feedstocks, microbial biosynthesis reduces or eliminates the need for petrochemical sources, elevated temperatures, toxic heavy metal catalysts, extremes of acidity and dangerous solvents, Koffas said.
In addition, the natural enzymes the UB researchers are using can facilitate chemical reactions that are difficult to accomplish through conventional chemistry, such as chiral synthesis, glycosylations and targeted hydroxylations, common but challenging steps in many syntheses.
"We are finding out how we can actually 'train' microbial systems to produce high yields of chemicals to be used as pharmaceuticals and to make production processes more efficient, less expensive and more environmentally friendly," Koffas said.
As with any commercial endeavor, process efficiency is a critical concern, he noted.
In work published in Applied and Environmental Microbiology in June, Koffas and his colleagues produced about 400 milligrams of flavonoids per liter of cell culture, far above the next highest yield of about 20 milligrams per liter produced by other microbial synthesis efforts.
"We have done this by increasing the amount of precursor available and re-engineering the native microbial metabolism," he explained, adding that they have taken different approaches to identifying the pathways that lead to the biosynthesis of precursors for desired compounds.
"Further improvement of production yields are possible and various approaches are being pursued by our team at this time," he said.
Another major challenge for microbial biosynthesis is that the enzymes required for certain chemical steps have special requirements that the host cell cannot meet efficiently, Koffas said. In some cases, the enzyme needs to be re-engineered, while in others the host cell needs modification.
Koffas' lab recently achieved the functional expression in E. coli of P450 monooxygenases, enzymes that are used widely in nature, but are not readily expressed in most industrially important microorganisms.
"P450 is very important in the synthesis of natural products," said Koffas. "For example, both Taxol, the breast cancer drug that is currently produced from plant cultures, and artemisinin, the anti-malaria drug, have P450 enzymes in their biosynthetic pathways."
The Koffas lab has introduced ways to modify both the P450 monooxygenase enzymes and the host cell, thereby improving their yield of flavonoids.
Microbial biosynthesis methods also are making it easier to create analogs of existing drugs, as well as new molecules for a broad range of therapeutics.
The UB researchers are particularly interested in developing novel molecules that can be used to treat chronic diseases, such as type II diabetes and obesity.
They also are using the methods to produce specialty compounds, such as natural pigments, that could replace chemical dyes in food.
Koffas' goal is to employ these microbial synthesis methods for a wide variety of applications.
Flavonoids, which are of interest to pharmaceutical companies because of their antioxidant and anti-carcinogenic properties, are difficult to produce using currently available methods.
Microbial synthesis strategies also are being adapted by the UB researchers for the biosynthesis of other commercially significant classes of compounds, including vitamins, anti-cancer drugs, anti-parasitic drugs, dyes and food supplements.
The UB group is working on boosting yields further and hopes to achieve pilot scale production of flavonoids by the end of this year.
For further information on commercialization of this technology, please contact Mike Fowler, commercialization manager for bioinformatics and health sciences, in UB's Office of Science, Technology Transfer and Economic Outreach (STOR) at mlfowler@buffalo.edu.
For information on commercialization of SBIR-funded research on the biosynthesis of isoflavonoids, please contact Jack Daiss, technical director, First Wave Technologies at jack@firstwavetechnologies.com.
Koffas's research has received funding from the National Science Foundation, UB's New York State Center of Excellence in Bioinformatics and Life Sciences and the Independent Research and Development Fund of the UB Office of the Vice President of Research.
The University at Buffalo is a premier research-intensive public university, the largest and most comprehensive campus in the State University of New York. UB's more than 27,000 students pursue their academic interests through more than 300 undergraduate, graduate and professional degree programs. Founded in 1846, the University at Buffalo is a member of the Association of American Universities.
The University at Buffalo
First Wave Technologies, Inc., a technology development company based in UB's New York State Center of Excellence in Bioinformatics and Life Sciences, which is collaborating with the UB group, recently received a highly competitive Phase I Small Business Innovation Research (SBIR) grant from the National Science Foundation to focus on the biosynthesis of a popular group of flavonoids called isoflavonoids.
"Ultimately, we want to be able to take a designed E. coli off of the shelf and drop into it the enzymes that constitute a particular biosynthetic pathway in order to make exactly the product we want," said Mattheos A. G. Koffas, Ph.D., assistant professor of chemical and biological engineering in the School of Engineering and Applied Sciences and leader of the UB team.
The UB approach to synthetic chemistry addresses some of the major challenges in conventional industrial production of specialty chemicals.
Through the use of specially adapted bacteria, specialized enzymes and natural feedstocks, microbial biosynthesis reduces or eliminates the need for petrochemical sources, elevated temperatures, toxic heavy metal catalysts, extremes of acidity and dangerous solvents, Koffas said.
In addition, the natural enzymes the UB researchers are using can facilitate chemical reactions that are difficult to accomplish through conventional chemistry, such as chiral synthesis, glycosylations and targeted hydroxylations, common but challenging steps in many syntheses.
"We are finding out how we can actually 'train' microbial systems to produce high yields of chemicals to be used as pharmaceuticals and to make production processes more efficient, less expensive and more environmentally friendly," Koffas said.
As with any commercial endeavor, process efficiency is a critical concern, he noted.
In work published in Applied and Environmental Microbiology in June, Koffas and his colleagues produced about 400 milligrams of flavonoids per liter of cell culture, far above the next highest yield of about 20 milligrams per liter produced by other microbial synthesis efforts.
"We have done this by increasing the amount of precursor available and re-engineering the native microbial metabolism," he explained, adding that they have taken different approaches to identifying the pathways that lead to the biosynthesis of precursors for desired compounds.
"Further improvement of production yields are possible and various approaches are being pursued by our team at this time," he said.
Another major challenge for microbial biosynthesis is that the enzymes required for certain chemical steps have special requirements that the host cell cannot meet efficiently, Koffas said. In some cases, the enzyme needs to be re-engineered, while in others the host cell needs modification.
Koffas' lab recently achieved the functional expression in E. coli of P450 monooxygenases, enzymes that are used widely in nature, but are not readily expressed in most industrially important microorganisms.
"P450 is very important in the synthesis of natural products," said Koffas. "For example, both Taxol, the breast cancer drug that is currently produced from plant cultures, and artemisinin, the anti-malaria drug, have P450 enzymes in their biosynthetic pathways."
The Koffas lab has introduced ways to modify both the P450 monooxygenase enzymes and the host cell, thereby improving their yield of flavonoids.
Microbial biosynthesis methods also are making it easier to create analogs of existing drugs, as well as new molecules for a broad range of therapeutics.
The UB researchers are particularly interested in developing novel molecules that can be used to treat chronic diseases, such as type II diabetes and obesity.
They also are using the methods to produce specialty compounds, such as natural pigments, that could replace chemical dyes in food.
Koffas' goal is to employ these microbial synthesis methods for a wide variety of applications.
Flavonoids, which are of interest to pharmaceutical companies because of their antioxidant and anti-carcinogenic properties, are difficult to produce using currently available methods.
Microbial synthesis strategies also are being adapted by the UB researchers for the biosynthesis of other commercially significant classes of compounds, including vitamins, anti-cancer drugs, anti-parasitic drugs, dyes and food supplements.
The UB group is working on boosting yields further and hopes to achieve pilot scale production of flavonoids by the end of this year.
For further information on commercialization of this technology, please contact Mike Fowler, commercialization manager for bioinformatics and health sciences, in UB's Office of Science, Technology Transfer and Economic Outreach (STOR) at mlfowler@buffalo.edu.
For information on commercialization of SBIR-funded research on the biosynthesis of isoflavonoids, please contact Jack Daiss, technical director, First Wave Technologies at jack@firstwavetechnologies.com.
Koffas's research has received funding from the National Science Foundation, UB's New York State Center of Excellence in Bioinformatics and Life Sciences and the Independent Research and Development Fund of the UB Office of the Vice President of Research.
The University at Buffalo is a premier research-intensive public university, the largest and most comprehensive campus in the State University of New York. UB's more than 27,000 students pursue their academic interests through more than 300 undergraduate, graduate and professional degree programs. Founded in 1846, the University at Buffalo is a member of the Association of American Universities.
The University at Buffalo
Microorganism Current Events and Microorganism News RSSNew cell division mechanism discovered
A novel cell division mechanism has been discovered in a microorganism that thrives in hot acid. The finding may also result in insights into key processes in human cells, and in a better understanding of the main evolutionary lineages of life on Earth.
Earlier global warming produced a whole new form of life
Researchers from McGill University, along with colleagues from the California Institute of Technology, the Curie Institute in Paris, Princeton University and other institutions, have unearthed crystalline magnetic fossils of a previously unknown species of microorganism that lived at the boundary of the Paleocene and Eocene epochs, some 55 million years ago.
Extreme nature helps scientists design nano materials
Scientists are using designs in nature from extreme environments to overcome the challenges of producing materials on the nanometre scale.
The Structure of the Mre11 Protein Bound to DNA
Repairing breaks in the two strands of the DNA double helix is critical for avoiding cancer. In humans and other organisms, a molecular machine called the MRN complex is responsible for finding and signaling double-strand breaks (DSBs), then launching the error-free method of DNA repair called homologous recombination.
Compost heap bacteria could provide 10 percent of UK transport fuel needs
Bacteria found in compost heaps able to convert waste plant fibre into ethanol could eventually provide up 10% of the UK's transport fuel needs, scientists heard today (Tuesday 9 September 2008) at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin.
Symbiotic microbes induce profound genetic changes in their hosts
Though bacteria are everywhere - from the air we breathe and the food we eat to our guts and skin - the vast majority are innocuous or even beneficial, and only a handful pose any threat to us. What distinguishes a welcome microbial guest from an unwanted intruder?
Researchers crack final part of the immune system code
A group of researchers at the Technical University of Denmark and the University of Copenhagen have developed models of neural networks that make it possible to simulate how the body protects itself from disease and predict the immune system's access codes.
Microrobots dance on something smaller than a pin's head
Microscopic robots crafted to maneuver separately without any obvious guidance are now assembling into self-organized structures after years of continuing research led by a Duke University computer scientist.
The Sweet World of Soil Microbiology
Using classroom, hands-on activities can help instructors to communicate difficult scientific concepts and stimulate student thinking. Despite its importance, the diversity in soil microbes can conceptually be difficult to teach, especially in natural resource classrooms composed primarily of undergraduates who have had little exposure to microbiology. That's where the candy comes into play.
To keep mouths safe, don't just wear a mouthguard; keep it clean
Fractured teeth, neck injuries and abrasions in the mouth, also known as sports-related dental injuries, are ever present among athletes. According to the U.S. Centers for Disease Control, sports-related dental injuries account for more than 600,000 emergency room visits each year.
More Microorganism Current Events and Microorganism News Articles
 | Brock Biology of Microorganisms (12th Edition) by Michael T. Madigan, John M. Martinko, Paul V. Dunlap, David P. Clark The authoritative text for introductory microbiology, Brock Biology of Microorganisms, 12/e, continues its long tradition of impeccable scholarship, outstanding art and photos, and accuracy. It balances the most current coverage with the major classical and contemporary concepts essential for understanding microbiology. Now reorganized for greater flexibility and updated with new content, the... |
 | Microorganisms in Home and Indoor Work Environments: Diversity, Health Impacts, Investigation and Control Despite the large amount of money spent on research into pollution of the indoor environment, the problem remains complex with major gaps in our knowledge of the identities and sources of pollutants and of the effects of prolonged exposure to indoor pollutants on health. Microorganisms in Home and Indoor Work Environments considers one such group of pollutants, namely microorganisms, and more... |
| Brock Biology Microorganism Oregan State University by Burke | |
 | Microorganisms in Foods 7: Microbiological Testing in Food Safety Management by International Commission for the Microbiological Specifications of Foods (ICMSF) Continuing this excellent series, Microorganisms in Foods 7 describes the role of microbiological testing in modern food safety management systems. It explores how risk assessment and risk management can be used to establish goals - known as "tolerable levels of risk" or "food safety objectives" - for use in controlling foodborne illness, and provides guidelines for establishing effective... |
 | Accessing Uncultivated Microorganisms: From the Environment to Organisms and Genomes and Back This book provides a comprehensive overview and discusses the latest developments in the field. It details various innovative methods for assessment of microbes both within and outside of the laboratory. It reviews many different methods used in microbial ecology and environmental microbiology. It presents chapters authored by world-renowned experts in the field. It highlights various aspects of... |
| Microorganisms, Fungi, and Plants (Holt Science & Technology) by Katy Z. Allen, Linda R. Berg | |
| Holt Science & Technology: Teaching Resources for Microorganisms, Fungi & Plants (Teaching Resources for Micro-Organisms, Fungi & Plants) Book contains: Directed Reading Worksheets; Study Guide including Vocabulary & Notes Worksheets & Chapter Review Worksheets; Science Puzzlers, Twisters & Teasers; Reinforcement & Vocabulary Review Worksheets; Critical Thinking & Problem Solving Worksheets; Math Skills for Science Worksheets; Science Skills Worksheets; Datasheets for Labs; Whiz-Bang Demonstrations; Calculator-Based Labs; EcoLabs... | |
| Factors Affecting Life and Death of Microorganisms (Microbial Ecology of Foods Vol 1) | |
 | Microorganisms in Foods 6: Microbial Ecology of Food Commodities (Microorganisms in Foods) by International Commission on Microbiological Specifications of Foods (ICMSF) The second edition of Microorganisms in Foods 6: Microbial Ecology of Food Commodities is for those primarily interested in applied aspects of food microbiology. For 17 commodity areas, it describes the initial microbial flora and the prevalence of pathogens, the microbiological consequences of processing, typical spoilage patterns, episodes implicating those commodities with foodborne illness,... |
 | Halophilic Microorganisms and their Environments (Cellular Origin, Life in Extreme Habitats and Astrobiology) by A. Oren The halophilic microorganisms form a highly diverse group of organisms. They present the biochemist/physiologist with interesting questions on the strategies used to cope with high osmotic pressures exerted by hypersaline brines. They often have a strong impact on the ecosystems in which they thrive. The first section of the book presents in-depth discussions of the taxonomy, cellular properties,... |
| © 2008 BrightSurf.com |